Skip to Main Content

Paper Details

Discordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer.
J Mol Diagn
18
2022
Author NameAffiliation
Jane BayaniOntario Institute for Cancer Research, University of Toronto
Elizabeth Mallon
Gregory R PondMcMaster University
Tammy PiperInstitute of Genetics and Cancer, The University of Edinburgh
Annette HasenburgUniversity Center Mainz
Christos MarkopoulosNational and Kapodistrian University of Athens Medical School
Luc DirixOncology Center, St. Augustinus Hospital
Caroline SeynaeveErasmus MC Cancer Institute
Cornelis J H van de VeldeLeiden University Medical Center
Daniel ReaCancer Research UK Clinical Trials Unit, University of Birmingham
John M S BartlettOntario Institute for Cancer Research, University of Toronto, Institute of Genetics and Cancer, The University of Edinburgh
  • 1 - 11

Datasets

Release 1.2